Organisation: Luxembourg Centre for Systems Biomedicine (LCSB)

  • News

    Investigating the modulation of the COVID-19 immune response

    In a recent paper, the research team around Prof. Antonio del Sol from the University’s Luxembourg Centre for Systems Biomedicine (LCSB) describes a new method of how molecules can be identified that amplify and maintain the inflammatory response upon an infection. They use their novel method to identify these molecules in COVID-19 patients and suggest…

    Learn more
  • News

    Scientists call for synchronised curbing of COVID infections in Europe

    Hundreds of scientists have called on European decision-makers to take steps for a quick, synchronised and efficient reduction in the number of COVID-19 cases across Europe.

    Learn more
  • News

    University and LIH translate research into clinical development

    The COVID-19 pandemic has shown that conducting strong translational research is key to combating the coronavirus. By leveraging cutting edge laboratory techniques to study patient samples, translational research quickly pivots laboratory discoveries into new therapies for patients, in a process known as the bench-to-bedside approach. Luxembourg has established excellent transversal and translational research, spanning several…

    Learn more
  • News

    LCSB partners with SciCrunch to promote reproducibility of research

    As part of a broad initiative aiming to guarantee research quality and reproducibility of scientific results, the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg is partnering with SciCrunch Inc. The LCSB will be one of the first academic institutions to use SciScore – an automated validation tool for scientific articles –…

    Learn more
  • News

    pdp 2.0: Individually tailored dementia prevention

    In Luxembourg, more people shall be able to reduce their risk of developing dementia

    Learn more
  • News

    University researchers win FNR Awards 2020

    The Luxembourg National Research Fund (FNR) has presented the FNR Awards 2020, conferring five awards to researchers and administrative staff from the University of Luxembourg on 19 November.

    Learn more
  • News

    The University launches the Institute for Advanced Studies

    The University of Luxembourg has launched an Institute for Advanced Studies (IAS) with the aim to strengthen its interdisciplinary research. The IAS will further reinforce the University’s international profile as an excellent research university. It will act as a promoter to overcome boundaries between different scientific disciplines and sectors. 

    Learn more
  • News

    Foyer Group supports Uni.lu research with a donation of 100000 €

    In a context marked by the COVID-19 crisis, Foyer Group made several donations totalling €100,000 to the holders of four research projects at the University of Luxembourg. Due to exceptional health circumstances, the traditional cheque handover reception could not take place, but the Foyer management and the University representatives promised to keep in touch, in…

    Learn more
  • News

    New study highlights links between inflammation & Parkinson’s disease

    An international collaboration involving researchers from the Luxembourg Centre for Systems Biology (LCSB) at the University of Luxembourg established an association between inflammation and specific genetic mutations in Parkinson’s patients. The study, recently published in the scientific journal Brain, highlights two biomarkers that could be used to assess Parkinson’s disease state and progression. The results…

    Learn more
  • News

    New approach against Parkinson’s disease through stem cell research

    In a seven-year research effort, an international team of scientists has clarified the cause for certain genetic forms of Parkinson’s disease, and has identified potential pharmacological treatments. The interdisciplinary research team, led by Prof. Rejko Krüger, of the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, experimented on patient-based cell cultures in…

    Learn more